News

  1. Interview with Immunis Award Winner Sarah Spöck

    5 questions to Immunis award winner Sarah Spöck

    Last year Sarah Spöck inspired the jury about her project and won the Immunis Sponsorhip 2021. We talked to her about the prize and her project.

    Read more »
  2. Study "SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls"

    Current study: T cell response with IGRA test by Wantai

    Hemodialysis (HD) patients have an increased risk of severe SARS-CoV-2 infection. In the study „SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls“, the impact of a third vaccine dose (3D) on antibody levels and T cell response were assessed in HD patients and a healthy control group in a prospective cohort study consisting of 60 HD patients and 65 healthy controls.

    Read more »
  3. Bethyl Laboratories, Inc.

    New manufacturer Bethyl Laboratories

    Bethyl has been dedicated to improving lives by supporting scientific discovery through its qualified antibody products and custom services since its founding in 1972. The company has a global reputation for quality and consistency.

    Read more »
  4. spheroid vs. organoid

    3D is not immediately 3D: what are spheroids, organoids and tissue models capable of in practice?

    Cultivation of cells outside their natural habitat in a laboratory with controlled conditions is indispensable for scientific research. In particular, 3D cultures reflect in vivo conditions in cell morphology, interaction and tissue-specific architecture and are therefore relatively close to native tissue.

    Read more »
  5. Lonza 4D-Nucleofector

    Trusted Transfection with the Next Generation 4D-Nucleofector Platform

    Life science researchers worldwide rely on Nucleofector Technology for transfecting hard-to-transfect cell lines and primary cells. Fast, consistent and reliable transfection results, Optimized Protocols for more than 750 cell types and excellent scientific support so you can focus on ground-breaking research.

    Read more »
  6. SZ-SC logo Ukraine flag colours

    Our contribution to Ukraine

    Szabo-Scandic has been supporting various social projects for many years. In this difficult time, we as employees also want to make a contribution to Ukraine.

    Read more »
  7. Immunis 2022 Szabo-Scandic and NGI

    Immunis Sponsorship for Young Science 2022 launched

    Two young talents are currently being sponsored by Szabo-Scandic as part of the Immunis Sponsorship for Young Science (Immunis). Now the new turn starts. Szabo-Scandic and NGI – the junior organization of the Austrian Society for Allergology and Immunology young scientists – announce the Immunis 2022.

    Read more »
  8. QuicKey Pro ELISA Kit from Elabscience

    Recently developed: QuicKey Pro ELISA Kits

    Ever since the discovery of theenzyme-linkedimmunosorbent assay (ELISA) in 1971, little has changed in the procedure. Only with the research of the two variants: Sandwich-ELISA and competitive ELISA, some development started. The QuicKey Pro ELISA Kits have been created.

    Read more »
  9. Research Trends 2020/21

    COVID-19 shapes future research plans

    A total of 83 drugs for human consumption and 10 for veterinarian use were approved for sale in the EU market in 2021. In the previous year, 2020, 90 human and 19 veterinarian drugs were approved. This displays a decline of 15%. Admittedly, 2020 was an exceptional year with a great number of approvals.

    Read more »
  10. positive Control SARS-CoV-2 from Microbix

    External SARS-CoV-2 positive Controls from the company Microbix

    Are you already using external SARS-CoV-2 controls to verify your RT PCR assays? SZABO-SCANDIC offers now two reliable controls manufactured by the company Microbix. The REDx™ FLOQ® SARS-CoV-2 Swab Positive Control and the REDx™ SARS-CoV-2 Positive Control (Vial) are available for you.

    Read more »